Dunn J T
Ann Intern Med. 1984 Jun;100(6):891-3. doi: 10.7326/0003-4819-100-6-891.
We asked 54 thyroidologists how they would treat each of four patients having moderate hyperthyroidism of Graves' disease and a thyroid gland weighing 70 g (three to four times normal). For a 19-year-old woman, 67% of thyroidologists recommended an initial course of therapy with antithyroid drugs, usually for 1 year; 24% favored radioiodine treatments; and 9%, surgery. Choices for treating a 19-year-old man were similar. For a 29-year-old man, 44% of thyroidologists preferred drug therapy; 50%, radioiodine; and 6%, surgery. For a 29-year-old woman, choices were similar to those for the 29-year-old man, except for a slight preference for drugs over radioiodine. If hyperthyroidism recurred after a first course of antithyroid drugs, the consultants favored radioiodine treatments and surgery about equally, except in the 29-year-old man, in whom radioiodine was preferred. This survey shows considerable variation among experts in treating hyperthyroidism in young adults.
我们询问了54位甲状腺专家,对于4名患有格雷夫斯病中度甲状腺功能亢进且甲状腺重70克(正常的三到四倍)的患者,他们会如何进行治疗。对于一名19岁女性,67%的甲状腺专家推荐初始疗程使用抗甲状腺药物,通常为期1年;24%倾向于放射性碘治疗;9%选择手术。治疗一名19岁男性的选择类似。对于一名29岁男性,44%的甲状腺专家更倾向于药物治疗;50%选择放射性碘;6%选择手术。对于一名29岁女性,选择与29岁男性类似,只是相较于放射性碘,对药物治疗略有偏好。如果在首个抗甲状腺药物疗程后甲状腺功能亢进复发,专家们对放射性碘治疗和手术的青睐程度大致相同,但29岁男性除外,该年龄段更倾向于放射性碘治疗。这项调查显示,专家们在治疗年轻成年人甲状腺功能亢进方面存在相当大的差异。